abinitio bio

Drug developers must assess candidate developability, move through process development and scale-up, run manufacturing, and assemble quality and regulatory evidence before approval. These stages span developability, process development, scale-up, manufacturing, quality, and regulatory work, each requiring careful review and documentation. Without a unified operating layer, decisions, model outputs, parameters, and approvals across these steps can be hard to track and audit in a GxP-regulated environment.

abinitio bio offers an operating platform that spans Assess, Develop, Operate, and Approve stages of drug development and manufacturing. It helps assess candidate developability and identify what needs improvement, accelerates process development, scale-up, and production, and supports evidence assembly and drafting for quality and regulatory needs. The platform is built as a GxP-native operating layer with a full audit trail recording sources, models, parameters, changes, reviews, and approvals. It allows customers to deploy their own models in their own environment, keeping their data and outputs under their control, and includes built-in review gates, version history, and accountable approvals.